Trial Profile
The effect of Aliskiren for microalbminurea of diabetic patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 10 May 2011 New trial record